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The Journal of Immunology
Activation of the Pyrin Inflammasome by Intracellular
Burkholderia cenocepacia
Mikhail A. Gavrilin,*,†,1 Dalia H. A. Abdelaziz,†,‡,1 Mahmoud Mostafa,†
Basant A. Abdulrahman,†,‡,x Jaykumar Grandhi,* Anwari Akhter,†,x Arwa Abu Khweek,†,x
Daniel F. Aubert,{ Miguel A. Valvano,{ Mark D. Wewers,*,† and Amal O. Amer*,†,x
Burkholderia cenocepacia is an opportunistic pathogen that causes chronic infection and induces progressive respiratory inflam-
mation in cystic fibrosis patients. Recognition of bacteria by mononuclear cells generally results in the activation of caspase-1 and
processing of IL-1b, a major proinflammatory cytokine. In this study, we report that human pyrin is required to detect intra-
cellular B. cenocepacia leading to IL-1b processing and release. This inflammatory response involves the host adapter molecule
ASC and the bacterial type VI secretion system (T6SS). Human monocytes and THP-1 cells stably expressing either small
interfering RNA against pyrin or YFP–pyrin and ASC (YFP–ASC) were infected with B. cenocepacia and analyzed for inflam-
masome activation. B. cenocepacia efficiently activates the inflammasome and IL-1b release in monocytes and THP-1. Suppression
of pyrin levels in monocytes and THP-1 cells reduced caspase-1 activation and IL-1b release in response to B. cenocepacia
challenge. In contrast, overexpression of pyrin or ASC induced a robust IL-1b response to B. cenocepacia, which correlated with
enhanced host cell death. Inflammasome activation was significantly reduced in cells infected with T6SS-defective mutants of
B. cenocepacia, suggesting that the inflammatory reaction is likely induced by an as yet uncharacterized effector(s) of the
T6SS. Together, we show for the first time, to our knowledge, that in human mononuclear cells infected with B. cenocepacia,
pyrin associates with caspase-1 and ASC forming an inflammasome that upregulates mononuclear cell IL-1b processing and
release. The Journal of Immunology, 2012, 188: 3469–3477.
C
hronic bacterial colonization and sustained inflammation
of the airways by opportunistic bacteria is the primary
cause of lung tissue damage and mortality in cystic fi-
brosis (CF) patients. CF is the most frequently inherited, lethal
disease of Caucasian individuals and is caused by mutations in the
cystic fibrosis transmembrane conductance regulator (CFTR) gene
located on human chromosome 7 (1). These mutations result in
malfunction of the CFTR protein leading to multiorgan dysfunc-
tion (2). However, nearly 85% of deaths in CF patients are asso-
ciated with progressive respiratory inflammation (3). In response
to the airway colonization by opportunistic bacteria, activated mac-
rophages induce a proinflammatory cytokine storm that contrib-
utes to inflammation and lung tissue destruction (4–7). Among the
bacteria infecting CF patients, members of the multidrug-resistant
Burkholderia cepacia complex and in particular Burkholderia cen-
ocepacia are important risk factors associated with poor prognosis.
These bacteria are extraordinarily resistant to almost all clinically
useful antibiotics, and some can cause a rapid and severe deterio-
ration of the lung function known as the cepacia syndrome (8).
Therefore, identifying the host factors involved in bacterial recog-
nition and elicitation of profuse inflammatory cytokine responses is
an urgent need to devise new ways to treat infected CF patients.
B. cenocepacia survives and proliferates within eukaryotic cells
such as amoebae, epithelial cells, and human macrophages (9–11).
Bacterial intracellular survival occurs in a membrane-bound com-
partment that shows a maturation delay resulting in a slow fusion
with lysosomes and delayed assembly of the NADPH oxidase
complex (12–15). Macrophages possess various Nod-like receptors
(NLRs) in the cytoplasm that interact with molecules from the
pathogens. Upon microbial recognition, NLRs initiate assembly of
a multiprotein complex called inflammasome (16). Protein partners
in the inflammasome possess either a caspase recruitment domain
(CARD) or a pyrin domain (PYD) and assemble via CARD–CARD
and PYD–PYD interactions (17, 18). The prototypical inflamma-
some consists of a CARD containing caspase-1, a CARD and
PYD-containing adapter molecule, ASC, and an NLR sensor of
pathogen- or danger-associated molecular patterns (PAMPs or
DAMPs). Depending on the presence of CARDs or PYDs, NLR
sensors are subdivided as NLRC or NLRP family members, re-
spectively (19). Because caspase-1 is the central protein of the
inflammasome and ASC is present in the majority of them, inflam-
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masomes are named based on the participating pattern recognition
receptor (NLR or other CARD or PYD containing protein). To date,
several NLR-based inflammasome structures have been described:
NLRP1 (16), NLRP3 (20), NLRC4 (IPAF) (21), and the NLRC5
(22). However, non-NLR proteins with a PYD may also initiate
the assembly of inflammasomes like RIG-I (23), AIM2 (24–27),
and pyrin (28, 29). Specific inflammasomes assembled in response
to the detection of intracellular Salmonella, Legionella, Listeria,
Francisella, Shigella, and Pseudomonas have been described (22,
29–39), but the inflammasome platform activated upon Burkhol-
deria infection is unknown.
Inflammasome assembly results in caspase-1 activation, which
subsequently cleaves biologically inactive pro–IL-1b to its active
17-kDa form (40, 41). IL-1b is the major proinflammatory cyto-
kine associated with the initiation of inflammatory reaction, tis-
sue destruction, and pyroptosis (42). To produce IL-1b, macro-
phages need two signals: one through TLR ligands that induce gene
transcription and another through NLR agonists that activate
caspase-1 via the inflammasome complex (43). We have previously
reported that B. cenocepacia induces pro–IL-1b synthesis via LPS
detection by TLR4 in murine macrophages (44). The subsequent
conversion of pro–IL-1b to the mature form depends on caspase-1
activation, as caspase-1 knockout mice did not release IL-1b in
response to B. cenocepacia (44). In this study, we show that human
pyrin is responsible for intracellular detection of B. cenocepacia to
induce IL-1b processing and release. This inflammatory response
requires the host adapter molecule ASC and the bacterial type VI
secretion system (T6SS).
Materials and Methods
Bacterial strains
B. cenocepacia strains (K56-2 clinical isolate and mutants) were cultured
as previously described (44). The bacterial type III secretion system (T3SS)
mutant JRL2 has an insertion inactivating bcsV, a critical gene of the type
III secretion apparatus. The T6SS mutant DFA2 carries a deletion of the
icmF gene (45). OD at 600 nm was used to calculate the multiplicity of
infection, which was further confirmed by plating serial dilutions of cul-
tures on Luria–Bertani agar and counting CFUs (46). Salmonella enterica
serovar Typhimurium (S. typhimurium), used as a control, was cultured as
described previously (47). For some experiments, bacteria were killed by
heat at 95˚C for 10 min.
Mononuclear phagocytes
THP-1 cells were purchased from American Type Culture Collection (lot
385653) and used to generate derivatives stably overexpressing or down-
regulating desired inflammasome proteins. Humanmonocytes were isolated
from fresh blood or buffy coat (local Red Cross) of healthy volunteers
by Histopaque-1077 (Sigma-Aldrich) followed by CD14-positive selection
(Miltenyi Biotec). This procedure consistently resulted in a $98% pure
population of CD14+ cells, as confirmed by flow cytometry. Purified mono-
cytes were used immediately after isolation. THP-1 cells and monocytes
were cultured in RPMI 1640 (MediaTech) supplemented with 10% heat-
inactivated FBS (Atlanta Biologicals).
In knockdown experiments, small interfering RNA (siRNA; Dharmacon)
was delivered in monocytes by nucleofection (Lonza). To knock down
pyrin, we used an ON-TARGETplus set of four siRNAs, each individually
verified to suppressMEFVexpression: 59-GCAGGCCCUUCGAAGUGUA-
39, 59-GCCCGCAAAUCCAGAAAUU-39, 59-GCAUAUGACACCCGCG-
UAU-39, 59-GCUACUGGGUGGUGAUAAU-39. In control nucleofections,
we used siGenome control siRNA. For nucleofection, 107 monocytes were
resuspended in 100 ml of nucleofection solution containing 150 pmol
siRNA. Nucleofection was performed with the Y-01 program. Immediately
after nucleofection, monocytes were resuspended in 5 ml Lonza medium
supplemented with 10% FBS and left to recover overnight in polypro-
pylene blue snap cap culture test tubes (Fisher Health Care) to avoid ad-
herence. The next morning, monocytes were counted with trypan blue
(Sigma) showing that 90% of cells were viable. Monocytes were trans-
ferred to polypropylene tubes and infected with B. cenocepacia at a mul-
tiplicity of infection (MOI) of 10 for 6 and 24 h and with S. typhimurium at
2.5 MOI for 4 h. In selected experiments, monocytes were pretreated with
5 mg/ml actin polymerization inhibitor cytochalasin D (Sigma-Aldrich)
for 30 min to block phagocytosis of bacteria. Released cytokines were
detected in cell culture medium while cells were lysed and analyzed for
protein and RNA.
Ethics statement
The procedure to isolate monocytes from blood samples of healthy donors
and the respective consent forms were approved by the Institutional Review
Board for human subject research at The Ohio State University (IRB
protocol number 2011H0059). All healthy donors provided written consent
for the collection of samples and subsequent analysis.
Construction of lentiviruses and generation of stable cell lines
To overexpress desired proteins, human ASC and pyrin were cloned into
the pLenti6/V5 TOPO vector (Invitrogen Life Technologies). For visual-
ization of the expressed proteins and sorting expressing cells, ASC and pyrin
were fused with C terminus of yellow fluorescent protein (YFP), as it was
described earlier (29). To express siRNA, we used the same pLenti6/V5
TOPO vector containing either green or red fluorescent proteins, where the
H1 promoter was inserted in front of the CMV promoter. Pyrin siRNA
(siPyrin) (59-CAGGGCAGCCATTCAGGAATA-39 and 59-GACCACTCC-
TCAAGAGATAAA-39) or control siRNA (siControl) (59-AAGCTGACC-
CTGAAGTTCA-39) oligonucleotides were ligated into the siRNA cassette
[59-CTAGCCC(sense)TTCAAGAGA(antisense)TTTTTGGAATT-39 and 59-
GGG(antisense) TCTCTTGAAT(sense) AAAAACCTTTAAGC-39]. Plas-
mids were verified by DNA sequencing. Each of these siPyrin constructs
suppressed pyrin levels by 70%. Packaging cell line HEK293-FT (Invi-
trogen Life Technologies) was transfected with pLenti and helper plasmids
pCMVDR8.2 and pMD.G to produce lentivirus. Cell culture medium
containing virus was harvested at 48 and 72 h posttransfection and con-
centrated at 3200 3 g for 30 min (Centricon C-20 columns, 100 000
MWCO; Amicon), resulting in a titer 1 3 107 to 2 3 107 TU/ml. Cells
were transduced with virus at 2–5 MOI in the presence of 6 mg/ml poly-
brene. After lentiviral transduction, 10–15% THP-1 cells expressed fluo-
rescent protein. Stably transduced cells were selected with blasticidin
(Invitrogen Life Technologies) for 10 d followed by two rounds of flow
sorting using FACSAria (Becton Dickinson), resulting in nearly homoge-
neous yield of stably transduced THP-1 cells. All cells were regularly
checked for the absence of Mycoplasma contamination (48).
Preparation of cell lysate, immunoblots, and ELISA
Cells were lysed in TN1 buffer [50 mM Tris-HCl (pH 8), 125 mM NaCl,
10 mMEDTA, and 1% Triton X-100] supplemented with complete protease
inhibitor mixture (Sigma), 1 mM PMSF, and 100 mM N-(methoxysuccinyl)-
Ala-Ala-Pro-Val chloromethyl ketone. The protein concentrations were de-
termined using Bio-Rad Dc protein Lowry assay (Bio-Rad). After SDS-PAGE
gel separation, samples were transferred to a nitrocellulosemembrane, probed
with the Ab of interest, and developed by ECL (Amersham Biosciences).
Rabbit polyclonal Abs against IL-1b, pyrin, ASC, and caspase-1 were
developed in our laboratory as described (49, 50). Other Abs were mono-
clonal anti-actin (clone C4; MP Biomedicals), monoclonal anti-enhanced
GFP (EGFP) (clone JL-8; Clontech), and monoclonal anti-ASC (MBL).
For immunoprecipitation, we used two approaches: standard pull-down
with Abs and with mMACS anti-EGFP magnetic beads (Miltenyi Biotec).
In pull-down experiments, ASC was immunoprecipitated with the rabbit
polyclonal anti-ASC Ab and then blotted with monoclonal anti-ASC, anti-
pyrin, and monoclonal anti-EGFP (if we used YFP-fused protein). For the
other approach, we used cell lines stably expressing either pyrin or ASC
fused with enhanced YFP. Cells were lysed, and magnetic beads conju-
gated with anti-EGFPAbs were added. Magnetically labeled proteins were
retained on a column, washed, and eluted. Eluate was subjected to im-
munoblot to detect proteins bound to the protein of interest.
Released IL-1b and caspase-1 were detected by immunoblot of cell
culture medium with our anti–IL-1b and caspase-1 Ab. In addition, IL-1b
and IL-8 in the cell culture medium were quantified using ELISA from
R&D Systems according to the manufacturer’s protocol.
Cell death detection by quantification of lactate dehydrogenase
release in cell culture media
Lactate dehydrogenase (LDH) release into cell culture medium was used as
an indicator of cell death using NAD+ reduction assay (Roche Applied
Science). Cells were plated in a 12-well plate at the density 1 3 106, and
10 MOI of B. cenocepacia or 2.5 MOI of S. typhimurium was added. Cell
culture medium was collected 4, 6, and 24 h postinfection, clarified from
floating bacteria by centrifugation, and used for LDH assay. To determine
spontaneous cell death (negative control), we collected medium from cells
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incubated at the same time without bacteria. Total LDH content in cells
(positive control) was measured in cells lysed with Triton X-100 (1% final
concentration). Cell culture medium alone was used as a blank, and OD
values were subtracted from readings of samples and positive control.
LDH concentration in the medium was detected at wavelength 490 nm.
Cell death was calculated by the formula [cytotoxicity (%) = (sample/
positive control) 3 100], as described earlier (51).
Real-time PCR
Cells were lysed in TRIzol (Invitrogen Life Technologies), and total RNA
was converted into cDNA by ThermoScript RT system (Invitrogen Life
Technologies). Quantitative PCR was done in the StepOne Plus machine
using SYBR Green PCR mix (Applied Biosystems). The values of target
genes were normalized to the values of two housekeeping genes, GAPDH
and CAP-1, and expressed as relative copy number, as described previously
(52–54).
Microscopy
For transmission electron microscopy, monocytes were fixed overnight in
2.5% glutaraldehyde in 0.1 M phosphate buffer with 0.1 M sucrose, washed,
and resuspended in 2% agarose to produce a solid matrix containing the cell.
The cells in agarose were postfixed in 1% osmium tetraoxide in phosphate
buffer and then en bloc-stained with 2% uranyl acetate in 10% ethanol,
dehydrated in a graded series of ethanol, and embedded in Eponate 12
epoxy resin (Ted Pella). Ultrathin sections were cut on a Leica EM UC6
ultramicrotome (Leica Microsystems, Wetzlar, Germany), collected on
copper grids, and then stained with lead citrate and uranyl acetate. Images
were acquired with an FEI Technai G2 Spirit transmission electron mi-
croscope (FEI) and a Macrofire (Optronics) digital camera and AMT im-
age capture software. For live time-lapse confocal microscopy, THP-1 cells
were stimulated with PMA at concentration 200 nM for 3 h. Then, cells
were washed three times and plated in 35-mm glass-bottom culture dishes
(MatTek) for 48 h, then infected with the K56-2 clinical isolate of B.
cenocepacia that expresses mRFP. Plates were transferred to a special
incubation chamber that provides 37˚C and 5% carbon dioxide and were
kept for 30 min for accommodation to the chamber atmosphere before the
image recording started. Images were taken using an Olympus Fluoview
FV10i microscope with 360 magnification. Pictures were taken at 1-min
intervals for 2–6 h.
Statistical analysis
All experiments were performed a minimum of three (or four) independent
times and expressed as mean values 6 SD. Comparison of groups for
statistical difference were done using Student t test. A p value #0.05 was
considered significant.
Results
Depletion of pyrin in primary human monocytes and in the
immortal THP-1 cells results in reduced inflammasome
activation upon B. cenocepacia infection
To identify whether pyrin plays a role in themacrophage response to
B. cenocepacia, we modulated pyrin expression level in primary
human monocytes and evaluated their ability to release mature IL-
1b upon B. cenocepacia infection. siRNA against MEFV-coding
pyrin and control siRNA were introduced into primary human
monocytes by nucleofection. As expected, mRNA and pyrin pro-
tein levels were reduced after nucleofection with siPyrin, but not
with siControl (Fig. 1A). After overnight recovery, nucleofected
monocytes were evaluated for viability, seeded in polypropylene
tubes, and infected with B. cenocepacia for 6 and 24 h and S.
typhimurium for 4 h. Postinfection, IL1B and IL8 gene expression
and corresponding released cytokines were evaluated. Uninfected
nucleofected monocytes did not release detectable amounts of
IL-1b and showed minimal release of IL-8. Manipulation of pyrin
levels did not affect cytokine gene expression (Fig. 1B, 1E). Be-
cause gene expression is independent of the inflammasome-
induced processing and release of IL-1b, we evaluated inflamma-
some activity by measuring the release of mature IL-1b and active
caspase-1 from control and knockdown cells. In contrast to the
equal mRNA induction, the release of mature IL-1b in response to
B. cenocepacia was significantly lower in cells with reduced pyrin
levels (Fig. 1C). Active caspase-1 self-cleavage also diminished
in the cells with decreased pyrin levels (Fig. 1D) whereas the
FIGURE 1. Human monocytes with knocked-down pyrin release less IL-1b and active caspase-1 in response to B. cenocepacia. (A) Human monocytes,
either noninfected or infected with B. cenocepacia, show decreased pyrin expression at mRNA (MEFV relative copy numbers) and protein levels after
nucleofection with siPyrin RNA compared with siControl. (B) B. cenocepacia and S. typhimurium induce similar IL-1b mRNA expression in human
monocytes nucleofected with siControl and siPyrin RNA. Inflammasome-dependent release of mature IL-1b (C) and active caspase-1 (D) was significantly
lower for siPyrin monocytes infected with B. cenocepacia but not with S. typhimurium. Inflammasome-independent IL-8 mRNA synthesis (E) and cytokine
release (F) was similar between siControl and siPyrin monocytes infected with B. cenocepacia and S. typhimurium. Data are expressed as mean6 SD; n = 5
independent experiments. B.c., B. cenocepacia; NT, noninfected; siCtr, siControl; S.t., S. typhimurium.
The Journal of Immunology 3471
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inflammasome-independent IL-8 release was unaffected (Fig. 1F).
In contrast, S. typhimurium-induced caspase-1 activation and IL-1b
release by human monocytes was pyrin independent (Fig. 1B–F).
Thus, pyrin-regulated inflammasome activation was specific to B.
cenocepacia.
To provide further evidence that pyrin promotes IL-1b pro-
cessing and release in response to mononuclear cells infected with
B. cenocepacia, we used a human THP-1 cell line stably depleted
of pyrin (29) (Supplemental Fig. 1). Depletion of pyrin resulted in
significant decrease of IL-1b release after B. cenocepacia infec-
tion (Fig. 2A). Inflammasome-independent IL-8 release in re-
sponse to B. cenocepacia was independent of pyrin levels (Fig.
2B). Similarly, THP-1 response to S. typhimurium infection was
not affected by pyrin levels as no difference in IL-1b and IL-8
release was observed between siControl and siPyrin THP-1 cells
(Fig. 2C, 2D). These results confirm our observation with primary
human monocytes that decreased pyrin expression level results in
reduced inflammasome-dependent IL-1b release in response to
B. cenocepacia infection.
Pyrin overexpression enhances IL-1b secretion by THP-1 in
response to B. cenocepacia
To better understand the role of pyrin in the innate immune re-
sponse to B. cenocepacia infection, we tested THP-1 cells stably
overexpressing YFP–pyrin (Supplemental Fig. 1). Mononuclear
cells were infected with B. cenocepacia or S. typhimurium, and
IL-1b and IL-8 release was measured. YFP–pyrin–expressing
THP-1 cells released significantly more IL-1b compared with
control THP-1 cells (Fig. 3A). This process is inflammasome-
dependent because no difference in inflammasome-independent
IL-8 release was observed between these two cell types infected
with B. cenocepacia (Fig. 3B). The majority of IL-1b release by
THP-1 cells overexpressing YFP–pyrin was observed at early
time points (6 h postinfection with B. cenocepacia) compared
with 24 h (Fig. 3A). At 6 h, active caspase-1 (p20) accumulated in
supernatants concurrently with IL-1b but only in cells over-
expressing pyrin, whereas there was no difference at 24 h (Sup-
plemental Fig. 2). Caspase-1 p20 release correlated with mature
IL-1b release and was enhanced by pyrin expression levels (Sup-
plemental Fig. 2).
Because pro–IL-1b and mature IL-1b are indistinguishable by
ELISA, we analyzed supernatants by immunoblots (Supplemental
Fig. 2). Cells overexpressing YFP–pyrin released more processed
IL-1b at 6 h postinfection with B. cenocepacia compared with
THP-1 cells. In contrast, YFP–pyrin–expressing cells infected with
S. typhimurium did not show augmented inflammasome-dependent
IL-1b or inflammasome-independent IL-8 release (Fig. 3C, 3D).
These data suggest that pyrin-augmented inflammasome activation
is pathogen specific and results from B. cenocepacia but not from
S. typhimurium infection.
Host cell death in response to B. cenocepacia correlates with
pyrin expression levels
To test whether caspase-1 activation and IL-1b accumulation in the
cell culture medium was associated with pyroptosis, we measured
LDH release by THP-1 cells expressing different pyrin levels. LDH
release by THP-1 cells expressing YFP–pyrin was significantly
elevated at 6 and 24 h after infection with B. cenocepacia compared
with that of control THP-1 cells (Fig. 4A). However, pyrin knock-
down did not reduce the percent of cell death in response to B.
cenocepacia in comparison with control THP-1 cells (Fig. 4B).
This discrepancy suggests that pyrin levels may have a threshold
relationship with pyroptosis but a more uniform linear relationship
with IL-1b processing. At the same time, S. typhimurium-induced
cell death was massive and did not correlate with the pyrin ex-
FIGURE 2. Pyrin downregulation decreases IL-1b release by THP-1
cells infected with B. cenocepacia. THP-1 cells, stably expressing
siControl or siPyrin, were infected with B. cenocepacia, and cell culture
medium was collected 6 and 24 h later for cytokine detection by ELISA.
(A) THP-1 stably suppressing pyrin (siPyrin) showed significantly lower
release of inflammasome-dependent IL-1b at 24 h postinfection compared
with the THP-1 expressing siControl. (B) Inflammasome-independent IL-8
release was equal between siControl- and siPyrin-expressing THP-1 cells.
(C and D) The same cells as in (A) were infected with S. typhimurium for
4 h. There was no difference in IL-1b and IL-8 release between siControl-
and siPyrin-expressing THP-1 cells. Data are expressed as mean6 SD; n =
4 independent experiments. B.c., B. cenocepacia; NT, noninfected; siCtr,
siControl; S.t., S. typhimurium.
FIGURE 3. Pyrin overexpression enhances IL-1b release in response
to B. cenocepacia. (A) THP-1 cells, stably expressing YFP–pyrin, showed
significantly higher inflammasome-dependent IL-1b release in response
to B. cenocepacia compared with the control THP-1 cells. (B) Inflamma-
some-independent IL-8 release was similar between control and YFP–
pyrin–overexpressing THP-1 cells infected with B. cenocepacia. (C and D)
The same cells were infected with S. typhimurium for 4 h. There was no
difference in IL-1b and IL-8 release between THP-1 varying in pyrin
levels. Data are expressed as mean 6 SD; n = 4 independent experiments.
B.c., B. cenocepacia; NT, noninfected; S.t., S. typhimurium.
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pression levels (Fig. 4C, 4D). Hence, pyrin overexpression pro-
motes early LDH release in response to B. cenocepacia, which
correlates with early inflammasome activation and IL-1b release as
discussed earlier.
ASC overexpression is associated with enhanced IL-1b release
by THP-1 cells in response to B. cenocepacia
Inflammasome activation usually requires the presence of the
universal adapter protein, ASC, which links the PYD of intra-
cellular sensors of pathogens with the CARD of caspase-1 (55). To
check whether enhancement of IL-1b release in response to B.
cenocepacia infection of monocytes is determined by inflamma-
some activation and requires ASC, we used two lines of THP-1
cells differing in ASC levels: one expressing endogenous ASC
only and the other stably overexpressing YFP–ASC. YFP–ASC–
expressing THP-1 cells showed significantly higher IL-1b release
in response to B. cenocepacia (Fig. 5A). This ASC effect is in-
dependent of NF-kB signaling, as IL-8 release in response to B.
cenocepacia was comparable in both cell types (Fig. 5B).
To determine whether the ASC-dependent inflammasome con-
tains pyrin upon B. cenocepacia infection, we studied ASC–
pyrin interactions in B. cenocepacia-infected cells at 6 h. Pyrin
coprecipitated with ASC after monocytes were infected with
FIGURE 4. THP-1 cells overexpressing pyrin show higher cell death
in response to B. cenocepacia infection. THP-1 cells with different levels
of pyrin expression were left untreated or infected with B. cenocepacia
for 6 and 24 h and with S. typhimurium for 4 h. Cell culture medium was
used to measure percentage of LDH release relative to the total LDH
content in the cell. (A) Pyrin overexpression leads to a significant in-
crease in LDH release 6 and 24 h postinfection with B. cenocepacia
compared with the control THP-1 cells. In contrast, pyrin knockdown did
not affect LDH release by THP-1 cells infected with B. cenocepacia. (B).
LDH release in response to S. typhimurium infection was equally high
between control THP-1 cells overexpressing pyrin (C) and knockdown of
pyrin (D). Data are expressed as mean 6 SD; n = 3 independent
experiments. B.c., B. cenocepacia; NT, noninfected; siCtr, siControl; S.t.,
S. typhimurium.
FIGURE 5. ASC important to B. cenocepacia response. THP-1 cells,
plain and overexpressing YFP–ASC, were infected with B. cenocepacia
for 6 and 24 h; cell culture medium was collected and analyzed for the IL-
1b and IL-8 release by ELISA. Data are expressed as mean 6 SD; n = 4
independent experiments. (A) Inflammasome-dependent IL-1b release in
response to B. cenocepacia was significantly higher in cells overexpressing
ASC. (B) Inflammasome-independent IL-8 release in response to B. cen-
ocepacia infection was similar between cells differing in ASC expression.
(C) ASC is colocalized with pyrin after infection with B. cenocepacia.
THP-1 cells were immunoprecipitated with anti-ASC Ab and immuno-
blotted for ASC and pyrin. (D) Pyrin is colocalized with ASC after in-
fection with B. cenocepacia. YFP–pyrin from stably transfected THP-1
cells was captured on magnetic beads conjugated with anti-EGFP Ab,
washed, and eluted. Cell extract (CE), flow through (F), and eluate from
untreated (2) or B. cenocepacia treated (+) cells were immunoblotted.
ASC was bound to YFP–pyrin only after infection with B. cenocepacia.
B.c., B. cenocepacia; NT, noninfected.
FIGURE 6. ASC and pyrin are colocalized with intracellular B. cenocepacia. (A) Transmission electron microscope imaging of human monocytes
infected with B. cenocepacia (B.c.) shows that this bacteria is taken up intracellularly (black arrow). (B) THP-1 cells stably expressing YFP–pyrin were
infected with an RFP-expressing K56.2 clinical isolate of B. cenocepacia. Intracellular RFP-Burkholderia (B.c.) was colocalized with YFP–pyrin (white
arrow) just prior to microscopic evidence of cell death. This is a representative image from Supplemental Video 1. (C) THP-1 cells stably expressing YFP–
ASC were infected with RFP-B. cenocepacia. Intracellular B. cenocepacia (B.c.) induced rapid pyroptosis after colocalization with YFP–ASC (white
arrow). This is a representative image from Supplemental Video 2.
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B. cenocepacia, but no coprecipitation was detected in uninfected
cells (Fig. 5C, 5D).
YFP–ASC and YFP–pyrin colocalize with
B. cenocepacia-containing phagosomes
Electron microscopy documented that B. cenocepacia infects
mononuclear phagocytes and resides in a phagosome (Fig. 6A).
We used confocal time-lapse microscopy to follow the redistri-
bution of YFP–pyrin or YFP–ASC in THP-1 cells infected with B.
cenocepacia expressing RFP (Fig. 6B, 6C; Supplemental Videos 1
and 2). Homogeneous cytoplasmic YFP–pyrin or YFP–ASC rap-
idly concentrated into a single speck containing intracellular RFP-
expressing B. cenocepacia. However, the initial patterns of pyrin
oligomerization are different from ASC speck formation. Pyrin
first appears to form oligomers concentrated on the cell membrane
(Supplemental Video 1). Notably, YFP–ASC–expressing THP-1
cells also released microvesicles that contain ASC (and IL-1b,
data not shown). After phagocytosis, both YFP–pyrin and YFP–
ASC colocalized with the B. cenocepacia-containing phagosome
generating a single ASC speck (Fig. 6B, 6C), which was immedi-
ately followed by cell dissolution (presumed cell death) (Supple-
mental Video 2). Together, biochemical and microscopy experiments
FIGURE 7. T6SS is important in inflammasome ac-
tivation in response to B. cenocepacia. Human mono-
cytes (HM) (A) and THP-1 cells (B) were infected
with B. cenocepacia WT and with mutants of type VI
and type III secretion systems, respectively (T6SS and
T3SS). Cells were lysed (CE) for detection of the
levels of pro–IL-1b synthesis upon bacterial infec-
tion, and cell culture medium was used to determine
whether mature IL-1b and active caspase-1 are re-
leased, as a signature of inflammasome activation. All
bacteria types equally induce pro–IL-1b synthesis in
human monocytes (A) and THP-1 cells (B). However,
mutation of T6SS reduces inflammasome activation
and caspase-1 and IL-1b release into cell culture me-
dium. NT, noninfected.
FIGURE 8. Internalization of live B. cenocepacia
is important for T6SS-dependent inflammasome ac-
tivation. Human monocytes were infected with live
or heat-killed B. cenocepacia for 6 h. To inhibit
bacteria internalization, monocytes were pretreated
for 30 min with 5 mg/ml cytochalasin D. NF-kB
activation, measured by mRNA expression for IL1B
(A), IL8 (D), and IL-8 release (E), shows no differ-
ence between WT and T6SS mutants of B. cen-
ocepacia. Pro–IL-1b synthesis was also equal be-
tween experimental groups, based on immunoblot
of cell lysates (C). Inflammasome-dependent IL-1b
release was significantly decreased in monocytes
infected with T6SS mutant, and also when bacteria
internalization was inhibited by cytochalasin D or
when bacteria were killed (B). Cell death, measured
by LDH release, correlates well with IL-1b release
(F). Data are expressed as mean 6 SD; n = 3 inde-
pendent experiments. *p , 0.05, **p , 0.005. cD,
cytochalasin D; K, heat-killed B. cenocepacia; L,
live B. cenocepacia; NT, noninfected.
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indicate that pyrin and ASC are involved in the formation of the
speck, which is accompanied by the production of IL-1b and cell
pyroptosis in response to B. cenocepacia.
B. cenocepacia type VI (T6SS) but not type III (T3SS) secretion
is essential for inflammasome activation and IL-1b and
caspase-1 release by mononuclear phagocytes
NLRs sense bacteria or their PAMPs in the cytoplasm of infected
cells. If the pathogen resides in a vacuole, the PAMPs could be
sensed by NLRs after bacterial molecules reach the cytoplasm,
which will require bacterial secretion systems. B. cenocepacia
harbors several secretion systems including type III, IV, and
VI (11, 56). To determine which secretion system is required to
engage the Burkholderia inflammasome leading to IL-1b pro-
duction, human monocytes were infected with the parental
B. cenocepacia strain K56-2 or with mutants in genes encoding
structural components of the type III and VI secretion systems.
K56-2, T3SS, and T6SS mutants show equal induction of pro–IL-
1b synthesis in human monocytes (Fig. 7A) and THP-1 cells (Fig.
7B). B. cenocepacia K56-2 and the T6SS mutant efficiently
engulfed bacteria (Supplemental Fig. 3). However, IL-1b and
active caspase-1 release were reduced in cells infected with the
T6SS mutant (Fig. 7A, 7B). We concluded that detection of B.
cenocepacia by pyrin and activation of the inflammasome requires
a functional bacterial T6SS.
To validate further the role of T6SS in inflammasome activation,
we infected human monocytes with live and heat-killed wild-type
(WT) and T6SS mutant B. cenocepacia. There was no difference
in NF-kB signaling between WT and T6SS mutant based on IL1B
and IL8 RNA expression and inflammasome-independent IL-8
release (Fig. 8A, 8D, 8E). Abrogation of bacteria internalization
with cytochalasin D did not affect NF-kB signaling. However,
IL-1b release, which depends on inflammasome activation, was
significantly lower for the T6SS mutant, cytochalasin D, and heat-
killed bacteria (Fig. 8B) despite adequate presence of precursor
IL-1b (Fig. 8C). Finally, LDH release correlated well with mature
IL-1b release (Fig. 8F).
Discussion
B. cenocepacia induces severe inflammation in the lung of CF
patients possibly by direct activation of macrophages, which results
in strong proinflammatory responses (7, 57). Intense inflammation
compromises lung tissue integrity and leads to progressive respi-
ratory failure or cepacia syndrome, resulting in death. High levels
of IL-1b, the caspase-1 substrate, are detected in the serum and
bronchoalveolar lavages of B. cenocepacia-infected CF patients (6,
58, 59). In support of this model, we have recently shown that
CFTR-defective macrophages produce more IL-1b than normal
macrophages during B. cenocepacia infection (44).
Macrophage activation is initiated by B. cenocepacia LPS and
depends on CD14, TLR4, and MyD88 in human and murine
models (44, 60). This results in secretion of many proinflammatory
cytokines. However, murine macrophages stimulated with highly
purified B. cenocepacia LPS produce pro–IL-1b but do not release
mature IL-1b (61). Cleavage and release of the major proin-
flammatory cytokine IL-1b depends on the activation of caspase-1,
which is tightly regulated by the inflammasome (17). To stimulate
pro–IL-1b cleavage and release, B. cenocepacia must be detected
intracellularly. In this study, we demonstrate for the first time, to
our knowledge, that pyrin regulates caspase-1 activation in human
monocytes in response to B. cenocepacia infection.
Pyrin is a protein in which several conserved mutations result in
familial Mediterranean fever and belongs to the tripartite motif
family of proteins, all of which share structural homology (62).
Although pyrin has an N-terminal PYD, it was not initially rec-
ognized as a member of the NLR family of intracellular sensors of
pathogens. However, we have recently shown that modulation of
intracellular pyrin levels in human mononuclear cells infected
with Francisella novicida also affects caspase-1 activation and
IL-1b release (29, 63). Pyrin interacts via its PYD with the adapter
protein ASC (64), and the two proteins colocalize in cellular sites
rich in polymerizing actin (65). The CARD of the ASC molecule
can interact directly with caspase-1 via its N-terminal CARD, and,
as a result, these three proteins may assemble into an inflamma-
some (28). During pyrin activation the PYD is unmasked, allow-
ing activated pyrin to interact with ASC and facilitate ASC
oligomerization (66). Then, the ASC oligomer serves as a molec-
ular platform for recruiting and activating caspase-1 (67, 68). Our
data suggest that the pyrin–ASC interaction is important in
intracellular B. cenocepacia detection and inflammasome or
pyroptosome activation. The pyroptosome is a single (one per cell)
1- to 2-mm supramolecular complex that contains ASC and
caspase-1. Pyroptosome assembly occurs within minutes of the
ASC speck complex formation and is associated with host cell
death (68). This type of cell death is uniquely dependent on
caspase-1 activation and named pyroptosis because of its ability to
induce IL-1b–dependent fever (69). The inflammasome forms
a ring-like structure with an outer diameter of ∼13 nm and an
inner diameter of ∼4 nm (70). Using time-lapse microscopy, we
observed the formation of pyrin and ASC specks within infected
macrophages. We also observed the formation of pyrin and ASC
complexes in the vicinity of the B. cenocepacia-containing vac-
uole. To our knowledge, this is the first documented interaction of
pyrin with a bacterium.
The current work adds B. cenocepacia to the list of potential
pyrin targets. Because intracellular B. cenocepacia resides in
a phagosome, cytoplasmic activation of the inflammasome implies
escape or active secretion of bacterial molecules into the cytosol.
Recently, it was shown that P. aeruginosa activates the inflam-
masome by secreting pilin, the major structural protein of type IV
pili, via a T3SS (71). In this study, we determined that T6SS of
B. cenocepacia is responsible for pyrin-dependent caspase-1 and
IL-1b processing and release by human mononuclear phagocytes.
The specific bacterial effector molecules initiating activation of
the pyrin inflammasome is a topic for future studies.
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